C. Difficile

Khalid Eljaaly, PharmD, MS, CAPPS, BCPS, explains why carbapenem antibiotics cause higher rates of C. diff and superinfections.

Khalid Eljaaly, PharmD, MS, CAPPS, BCPS, explains his team’s findings on the link between carbapenems and superinfections & Clostridium difficile.

Researchers believe that an increased incidence of C. difficile in travelers returning from international destinations may be linked to travelers' diarrhea.

Gonzalo Bearman, MD, MPH, professor of medicine, and hospital epidemiologist, Department of Internal Medicine and Infectious Diseases, Virginia Commonwealth University, explains how controlling antibiotic use can impact Clostridium difficile rates.

In a Phase 2 controlled clinical study, patients with Clostridium difficile infection receiving ridinilazole were found to have achieved better treatment outcomes than those receiving vancomycin.

Gonzalo Bearman, MD, MPH, professor of medicine, and hospital epidemiologist, Department of Internal Medicine and Infectious Diseases, Virginia Commonwealth University, discusses a cost-effective way to control Clostridium difficile in the hospital setting.

Gonzalo Bearman, MD, MPH, professor of medicine, and hospital epidemiologist, Department of Internal Medicine and Infectious Diseases, Virginia Commonwealth University, examines the importance of nurse-driven Clostridium difficile protocols.

What can healthcare providers do to stop these infections before they start?

Gonzalo Bearman, MD, MPH, professor of medicine, and hospital epidemiologist, Department of Internal Medicine and Infectious Diseases, Virginia Commonwealth University, discusses some alternative approaches to contact precautions for patients with Clostridium difficile.

Gonzalo Bearman, MD, MPH, professor of medicine, and hospital epidemiologist, Department of Internal Medicine and Infectious Diseases, Virginia Commonwealth University, discusses contact precautions for patients with Clostridium difficile.

Belinda Ostrowsky, MD, MPH, Health Systems Director of Epidemiology, Antimicrobial Stewardship & Infection Prevention, Montefiore Medical Center, and Associate Professor of Clinical Medicine, Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, discusses five stewardship strategies to help reduce healthcare-associated Clostridium difficile rates.

Gonzalo Bearman, MD, MPH, professor of medicine, and hospital epidemiologist, Department of Internal Medicine and Infectious Diseases, Virginia Commonwealth University, discusses the aggressiveness of infection prevention strategies to stop Clostridium difficile outbreaks.

Belinda Ostrowsky, MD, MPH, Health Systems Director of Epidemiology, Antimicrobial Stewardship & Infection Prevention, Montefiore Medical Center, and Associate Professor of Clinical Medicine, Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, discusses limitations to C. difficile testing that could impact stewardship practices in healthcare facilities.

Research coming in from the University of Texas Health Science Center at Houston shows that when it comes to treating those with C. difficile, frozen and freeze-dried products for Fecal Microbiota Transplantation are nearly as effective as fresh product.

News on Heliobacter pylori, Zika, Clostridium difficile, Powassan virus, and influenza make up the top 5 news articles from Contagion® in March 2017.

On March 30, 2017, at the SHEA Spring 2017 Conference, Thomas Sandora, MD, MPH, shared some tips regarding ways to manage movement outside of the room for patients who are on contact precautions.

Contagion® will be covering the conference, and so keep a look out for session coverage, as well as interviews with some of the key presenters.

In case you missed them, our top 5 articles for the week of March 19, 2017 are highlighted here.

Duke Health researchers have found that a UVC machine use can reduce transmission of harmful superbugs in hospital settings.

As emerging infectious diseases and resistant bugs become a growing issue, the need for stronger disinfectants becomes even more vital.

On March 5, 2017, at the 2017 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI), Gary Huang, MD, PhD, explained his research team's findings regarding self-reported allergy to drugs containing β-lactams.

Robin Jump, MD, PhD, assistant professor in the Department of Medicine at the Case Western Reserve University sat down with Contagion™ to discuss up-and-coming prevention methods for C. diff in the hospital setting.

In a new study, researchers found that patients with severe Clostridium difficile (C. diff) infections who were treated with vancomycin had lower mortality rates than patients who were treated with metronidazole.

A new study from the United Kingdom highlights the importance of antibiotic restriction in the reduction of hospital-acquired C. difficile infections.

Researchers found the experimental vaccine could potentially inhibit severe diarrhea and pseudomembranous colitis by inducing a functional antibody response that can neutralize the two main disease-causing toxins (toxin A or B) produced by C. difficile.

A new study has provided more evidence to show that certain heartburn medications may make individuals more susceptible to gastrointestinal infections.

A new study takes a look at the efficacy of off-label treatments for Clostridium difficile (C. difficile) infection.

Under a program established through the Affordable Care Act, 769 US hospitals will receive Medicare reimbursement reductions due to the high rates of hospital-acquired infections.

In mid-November, the CDC released the “Core Elements of Outpatient Antibiotic Stewardship.”

A study from University of Washington researchers uncovers how hospital laundry facilities may harbor dangerous Clostridium difficile spores, creating a potential community source for the bacterial pathogen.